Proton Pump Inhibitors and Clopidogrel

This publication has 18 references indexed in Scilit:

• Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
  Circulation, 2009
• Cytochrome P-450 Polymorphisms and Response to Clopidogrel
  New England Journal of Medicine, 2009
• Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel
  Thrombosis and Haemostasis, 2009
• Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
  American Heart Journal, 2009
• ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
  Circulation, 2008
• Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
  JACC, 2008
• Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients
  Pharmacogenetics and Genomics, 2007
• Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
  Blood, 2006
• Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
  Journal of Thrombosis and Haemostasis, 2006
• Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
  Circulation, 2003